Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121

AbbVie Buys a Pipeline

by | Apr 29, 2016 6:37 pm | Biotechnology, Pharmaceuticals

After only four deals announced in 2014 and 2015, AbbVie (NYSE: ABBV) gained momentum in the M&A space this year in an effort to expand and diversify its portfolio. The timing isn’t a coincidence, since it faces the looming expiration of Humira’s patent in December. The drug that accounted for 63% of AbbVie’s 2014 sales could lose its dominant position in the autoimmune disease market as competitive generics take the field. In the first four months of 2016, AbbVie has dished out $6.4 billion on three deals (two collaborations and one acquisition). On March 7th, the company announced a collaboration with Boehringer Ingelheim that added anti-IL-23 to its immunology pipeline. The... Read More »

Abbott’s $30.7B Deal Boosts Medical Device M&A

by | Apr 28, 2016 8:46 pm | Laboratories, MRI & Dialysis, Medical Devices, Pharmaceuticals

Medical device deals are back in fashion. In the first four months of 2016, 41 deals were announced in this sector, compared with just 30 for the comparable time period in 2015. Spending on deals in this sector has already hit $42.7 billion, compared with $5.7 billion in the first four months of 2015. The largest by far this year is Abbott’s (NYSE: ABT) announcement on April 28 that it would spend $30.7 billion to acquire Minneapolis-based St. Jude Medical, Inc. (NYSE: SJM). St. Jude shareholders will receive $46.75 in cash and 0.8708 shares of Abbott common stock, representing total consideration of approximately $85 per share, and a transaction equity value of $25 billion. Add in... Read More »

Veritas Capital Buys Back into Big Data

by | Apr 26, 2016 5:55 pm | eHealth, Private Equity

Big data firms are sweet targets for healthcare investors. Just last February, Veritas Capital sold Truven Health Analytics to IBM Watson Health (NYSE: IBM) for $2.6 billion. Now it’s putting some of that ROI into another big data firm, Verisk Health, the healthcare service business Verisk Analytics Inc. Verisk Health provides data services, analytics and advanced technologies to help users make smarter business decisions and reduce risk. The $820 million purchase price consists of $720 million in cash and a $100 million long-term subordinated promissory note. With Truven Health Analytics, Veritas Capital repositioned the company from a data provider with limited analytics offerings... Read More »

The End of Health Care’s Billion-Dollar Run?

by | Apr 24, 2016 9:29 pm | Healthcare Market Updates

Without thinking about it, we came to take the monthly list of billion-dollar-plus health care deals for granted. So came as a surprise when we began tallying the list of transactions announced in April.As of April 24, not one billion-dollar deal has been announced. Looking back through the DealSearchOnline database, at least one big deal has been announced every month since April 2013. That’s a 24-month streak, about to be broken. Obviously, we still have a week to go in this vernal month. The streak could continue. But if it doesn’t, you heard it here first.   Read More »

Another Anesthesia Group Changes Hands

by | Apr 21, 2016 8:00 am | Physician Medical Groups, Private Equity

Moelis Capital Partners is selling North American Partners in Anesthesia (NAPA), the largest single specialty anethesia management company in the United States, which it acquired in 2011. The buyers are American Securities LLC, a middle-market private equity firm, along with minority investments from Leonard Green & Partners and NAPA management. Specifically, the buyers completed a recapitalization of NAPA’s practice management company, NAPA Management Services Corporation. Financial terms were not disclosed, but Reuters News reported in February that American Securities was paying nearly $1 billion for NAPA. Read More »

naviHealth Buys Curaspan

by | Apr 20, 2016 4:42 pm | eHealth, Other Services, Private Equity

naviHealth is moving deeper into post-acute care transitions, in an effort to follow the bundled payments from end-to-end. Last week the company announced it will acquire Curaspan Health Group for an undisclosed amount. Just last August, naviHealth was the target in a $290 million deal, as Cardinal Health (NYSE: CAH) acquired 71% of the company from Welsh, Carson, Anderson & Stowe, with the goal of acquiring the remaining 29% within four years. naviHealth provides software and analytics to healthcare plans, health systems, physicians and post-acute care providers to manage the entire continuum of post-acute care. Curaspan Health specializes in care transition tools for hospitals and... Read More »

Other Healthcare Services Deals, 2006 to 2015

by | Apr 20, 2016 3:53 pm | Other Services

During 2015, 178 deals were announced in the “Other Services” sector, the highest number in the past five years. Because this category tracks a wide range of businesses that operate or perform services that support or are ancillary to the direct delivery of health care, the statistical significance of a surge or plunge is less relevant than it would be in a sector that tracks a specific service such as hospitals or rehabilitation. Included are pharmacy benefit management companies, ambulatory surgery centers, dental and dermatology practices, contract and clinical research organizations (CROs), and medical transport companies, among others. Read More »

Physician Medical Group Deals, 2006 to 2015

by | Apr 20, 2016 3:50 pm | Physician Medical Groups

After three years of declines, mergers and acquisitions picked up in 2015, reaching 88 deals. Just as hospitals, health insurers and others are seeking greater scale to boost efficiency and outcomes, physicians are joining larger management groups or health systems for the same reasons. In 2015, consolidation began among the biggest players—Team Health (NYSE: TMH) and IPC Healthcare—and more could be on the way. AmSurg Corporation (NASDAQ: AMSG), parent company to Sheridan, made a surprise bid for Team Health in August. That offer was rebuffed, to the chagrin of many Team Health shareholders. With the continuing shift to value-based health care and bundled payments, expect a few more big... Read More »

Pharmaceutical Deals, 2006 to 2015

by | Apr 20, 2016 3:50 pm | Pharmaceuticals

Drug manufacturers came under heavy scrutiny late in 2015, both for their pricing practices and their penchant for acquiring overseas rivals to gain lower corporate tax rates. The latter issue was the major impetus for the lrgest health care deal ever announced, Pfizer’s (NYSE: PFE) $160 billion takeover of Dublin-based Allergan plc (NYSE: AGN). The Treasury deparment moved quickly to change its rules on “inversions,” making them even more onerous. Pfizer walked away from the deal, not surprisingly. Public sentiment about the high price of many drugs, including generics, is having a chill effect on this sector. 2016 may turn out to be a quiet year for pharma deals, at... Read More »